Para-Substituted Thiosemicarbazones as Cholinesterase Inhibitors: Synthesis, In Vitro Biological Evaluation, and In Silico Study

被引:14
作者
Khan, Momin [1 ]
Gohar, Hina [1 ]
Alam, Aftab [2 ]
Wadood, Abdul [1 ]
Shareef, Azam [1 ]
Ali, Mahboob [1 ]
Khalid, Asaad [3 ,4 ]
Abdalla, Ashraf N. [5 ]
Ullah, Farhat [6 ]
机构
[1] Abdul Wali Khan Univ, Dept Chem, Mardan 23200, Pakistan
[2] Univ Malakand, Dept Chem, Chakdara 18800, Pakistan
[3] Jazan Univ, Subst Abuse & Toxicol Res Ctr, Jazan 45142, Saudi Arabia
[4] Natl Ctr Res, Med & Aromat Plants & Tradit Med Res Inst, Khartoum 11111, Sudan
[5] Umm Al Qura Univ, Coll Pharm, Dept Pharmacol & Toxicol, Mecca 21955, Saudi Arabia
[6] Univ Malakand, Dept Pharm, Chakdara 18800, Pakistan
来源
ACS OMEGA | 2023年
关键词
SCHIFF-BASES; ACETYLCHOLINESTERASE INHIBITION; VITRO; DERIVATIVES; COMPLEXES;
D O I
10.1021/acsomega.2c08108
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The current research reports the synthesis of 14 para-substituted thiosemicarbazone derivatives in good to excellent yields using standard procedures. Initially, 4-ethoxybenzaldehyde (1) and 4-nitrobenzaldehyde (2) were refluxed with thiosemicarbazide in the presence of acetic acid in ethanol for 4-5 h. Then, various substituted phenacyl bromides were treated with the desired thiosemicarbazones (3 and 4) in the presence of triethylamine in ethanol with constant stirring for 5-6 h. The resulting derivatives were confirmed through electron impact mass spectrometry and 1H NMR spectroscopy and evaluated for anticholinesterase inhibitory activity. Among the series, four compounds, 19, 17, 7, and 6, showed potent inhibitory activity against the acetylcholinesterase (AChE) enzyme, having IC50 values of 110.19 +/- 2.32, 114.57 +/- 0.15, 140.52 +/- 0.11, and 160.04 +/- 0.02 mu M, respectively, compared with standard galantamine (IC50 = 104.5 +/- 1.20 mu M). Similarly, compounds 19 (IC50 = 145.11 +/- 1.03 mu M), 9 (IC50 = 147.20 +/- 0.09 mu M), 17 (IC50 = 150.36 +/- 0.18 mu M), and 6 (IC50 = 190.21 +/- 0.13 mu M) were the most excellent inhibitors of butyrylcholinesterase (BChE) when compared with the standard drug galantamine (IC50 = 156.8 +/- 1.50 mu M). In silico studies were accomplished on the produced derivatives in order to explain the binding interface of compounds with the active sites of AChE and BChE enzymes.
引用
收藏
页码:5116 / 5123
页数:8
相关论文
共 50 条
  • [31] Synthesis, Biological Evaluation, and Molecular Modeling Study of Substituted Benzyl Benzamides as CETP Inhibitors
    Abu Khalaf, Reema
    Sabbah, Dima
    Al-Shalabi, Eveen
    Bishtawi, Samar
    Albadawi, Ghadeer
    Abu Sheikha, Ghassan
    [J]. ARCHIV DER PHARMAZIE, 2017, 350 (12)
  • [32] Design and Synthesis of New Dual Binding Site Cholinesterase Inhibitors: in vitro Inhibition Studies with in silico Docking
    Yar, Muhammad
    Bajda, Marek
    Mehmood, Rana Atif
    Sidra, Lala Rukh
    Ullah, Nisar
    Shahzadi, Lubna
    Ashraf, Muhammad
    Ismail, Tayaba
    Shahzad, Sohail Anjum
    Khan, Zulfiqar Ali
    Naqvi, Syed Ali Raza
    Mahmood, Nasir
    [J]. LETTERS IN DRUG DESIGN & DISCOVERY, 2014, 11 (03) : 331 - 338
  • [33] Novel indolyl linked para-substituted benzylidene-based phenyl containing thiazolidienediones and their analogs as α-glucosidase inhibitors: synthesis, in vitro, and molecular docking studies
    Kaur, Jeewanjot
    Singh, Amanjot
    Singh, Gagandeep
    Verma, Raman K.
    Mall, Rajiv
    [J]. MEDICINAL CHEMISTRY RESEARCH, 2018, 27 (03) : 903 - 914
  • [34] Synthesis, In Silico, and In Vitro Biological Evaluation of New Furan Hybrid Molecules
    Manolov, Stanimir
    Ivanov, Iliyan
    Bojilov, Dimitar
    Nedialkov, Paraskev
    [J]. PROCESSES, 2022, 10 (10)
  • [35] Synthesis and biological evaluation of new silicon(IV) phthalocyanines as carbonic anhydrase and cholinesterase inhibitors
    Cakir, Volkan
    Arslan, Tayfun
    [J]. INORGANICA CHIMICA ACTA, 2022, 530
  • [36] Synthesis and biological evaluation of new pyrazolone Schiff bases as monoamine oxidase and cholinesterase inhibitors
    Tok, Fatih
    Kocyigit-Kaymakcioglu, Bedia
    Saglik, Begum Nurpelin
    Levent, Serkan
    Ozkay, Yusuf
    Kaplancikli, Zafer Asim
    [J]. BIOORGANIC CHEMISTRY, 2019, 84 : 41 - 50
  • [37] Biological evaluation and in silico study of benzohydrazide derivatives as paraoxonase 1 inhibitors
    Korkmaz, Isil Nihan
    Turkes, Cuneyt
    Demir, Yeliz
    Oztekin, Aykut
    Ozdemir, Hasan
    Beydemir, Sukru
    [J]. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2022, 36 (11)
  • [38] Discovery of novel N -substituted thiazolidinediones (TZDs) as HDAC8 inhibitors: in-silico studies, synthesis, and biological evaluation
    Upadhyay, Neha
    Tilekar, Kalpana
    Jaensch, Niklas
    Schweipert, Markus
    Hess, Jessica D.
    Macias, Luca Henze
    Mrowka, Piotr
    Aguilera, Renato J.
    Choe, Jun-yong
    Meyer-Almes, Franz-Josef
    Ramaa, C. S.
    [J]. BIOORGANIC CHEMISTRY, 2020, 100
  • [39] Benzofuran Hybrids as Cholinesterase (AChE and BChE) Inhibitors: In Vitro, In Silico, and Kinetic Studies
    Ali, I
    Rafique, R.
    Khan, K. M.
    Chigurupati, S.
    Ji, X.
    Wadood, A.
    Rehman, A. U.
    Salar, U.
    Alyamani, N. M.
    Hameed, S.
    Taha, M.
    Hussain, S.
    Perveen, S.
    [J]. RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2022, 48 (06) : 1322 - 1337
  • [40] Synthesis and biological evaluation of some N4-substituted 5-nitroisatin-3-thiosemicarbazones
    Pervez, Humayun
    Manzoor, Nazia
    Yaqub, Muhammad
    Nasim, Faiz-ul-Hassan
    Khan, Khalid M.
    [J]. MEDICINAL CHEMISTRY RESEARCH, 2012, 21 (09) : 2251 - 2262